Clinical Trials in Chicago

Showing 12261-12280 of 17,609 trials

A Post-approval LAP-BAND® Lower Body Mass Index (LBMI) Study

NCT02356614

This is a post-approval, multicenter, prospective, non-randomized, open-label, clinical study to evaluate the safety and effectiveness of the LAP-BAND® AP System in a lower obese population (BMI ≥ 30 kg/m2 and \< 40 kg/m2) with one or more obesity-related comorbidity up to 10 years after implantation. The reason your study has been terminated is based on the availability of long-term safety and effectiveness data from the OSB Lead-HERo-002 study and published literature.

ObesityOverweight

Apollo Endosurgery, Inc.325 participantsStarted Mar 2015

Fountain Valley, California, United States • Champaign, Illinois, United States • Chicago, Illinois, United States +8 more locations

COMPLETEDNA2.2 miles

Innovative Tool to Increase Completion of Human Papillomavirus (HPV) Vaccine Series

NCT01343485

Planned Parenthood Federation of America's (PPFA) Medical Affairs Division will conduct a prospective, cluster randomized trial to determine which factors influence the acquisition of the second and third human papillomavirus (HPV) vaccine doses among young women ages 19 to 26. This descriptive and interventional study will provide data to assess impact of a computerized tool upon HPV vaccine series completion. The interventional aspect of this study includes determination of patient assistance and provider support programs applicable to each woman's situation as well as the implementation of a computer software system for customized patient reminders.

GARDASIL Vaccination

Planned Parenthood Federation of America365 participantsStarted Sep 2011

Glendale, Arizona, United States • Arvada, Colorado, United States • Denver, Colorado, United States +6 more locations

A Post-approval LAP-BAND® Lower Body Mass Index (LBMI) Study

Innovative Tool to Increase Completion of Human Papillomavirus (HPV) Vaccine Series

Find Trials by Condition in Chicago

An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD

Acute Study to Collect Electrical Signals From the Heart Using a Special Lead

VenaSeal Sapheon Closure System Pivotal Study (VeClose)

A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis

Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Synagis)

Clinical Evaluation of Lapsed Contact Lens Wearers Who Are Re-fit Into Senofilcon A Contact Lenses

Evaluation of the Performance of Two Contact Lenses Compared to a Marketed Lens

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer

A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Nausea and Vomiting

Non-Invasive Neurostimulation for the Prevention of Chronic Migraine

Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America

COOL-ARREST Pilot Study to Assess Intravascular Temperature Management (IVTM) in the Treatment of Cardiac Arrest

Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes

Dispensing Evaluation of Subjective Comfort, Vision, and Handling of a New Lens Compared to a Marketed Lens

Comparison of Two Daily Disposable Contact Lenses Over 1-week of Wear

Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets